Should there be systematic screening of coronary heart disease in asymptomatic patients with risk factors alone? A decision analysis approach.
The problem of choosing between detection of asymptomatic coronary heart disease (CHD) in patients at risk and primary prevention was assessed in a decision analysis model. Most of the relevant data were derived from the WOSCOP study, which evaluated the effects of statins in asymptomatic hypercholesterolaemic subjects. This study is considered to be a model of primary prevention measurement. Over a 5-year period, 10% of control subjects had events related to CHD, with a 20% mortality rate which was reduced by 33% under statin administration. A decision tree was used to compare these two sets of data (controls and treated patients) with those of a third option in which an exercise test, 201Tl scintigraphy and, in certain cases, coronary arteriography were used to detect and treat CHD at an asymptomatic stage. The test characteristics and outcomes correspond as closely as possible to previously reported data, concerning what can be expected in this particular situation. Over a wide range of CHD probabilities, screening appeared to be better than primary prevention. This result is robust since it was not modified by sensitivity analysis for most of the data. A sharp decrease in the sensitivity of the first two tests and a marked increase in the effectiveness of primary prevention would alter the decision in favour of primary prevention, whereas an increased death rate from CHD and higher CHD probability would favour the utility of screening. As the cost-effectiveness of screening compares favourably with that of primary prevention, it may be useful to assess the validity of this model in a prospective controlled study.